openPR Logo
Press release

Next Generation Sequencing Market to grow at a CAGR of 18.7% by 2026: Top Key Players Thermo Fisher Scientific, Roche, Illumina, QIAGEN, PerkinElmer, Inc., Agilent Technologies Pacific Biosciences , Myriad Genetics , Bio-Rad Laboratories and Eurofins

09-28-2018 02:11 PM CET | Health & Medicine

Press release from: Research for Markets

/ PR Agency: Research For Markets
Next Generation Sequencing Market

Next Generation Sequencing Market

The Next Generation Sequencing Market Report also provides an analytical assessment of the prime challenges faced by the Market currently, and in the coming years, which helps Market participants in understanding the problems they may face while operating in this Market over a longer period of time.

The Global Next Generation Sequencing market is expected to grow at a CAGR of 18.7% during the forecast period from 2017 to 2026.

Factors such as growing adoption of sequencing technologies in clinical applications and low cost DNA sequencing are likely to drive the market growth. On the other side, accuracy and standardization issues and lack of skilled labour are inhibiting the market growth. However, rise in personalize medicine and cloud computing are likely to create more opportunities for this market during the forecast period.

SOME OF THE KEY PLAYERS IN GLOBAL NEXT GENERATION SEQUENCING MARKET ARE

• Thermo Fisher Scientific Inc.,

• F. Hoffmann-La Roche AG,

• Illumina, Inc.,

• Beijing Genomics Institute,

• Qiagen N.V.,

• Pacific Biosciences of California, Inc.,

• Perkinelmer, Inc.,

• Agilent Technologies, Inc.,

• Gatc Biotech AG,

• Oxford Nanopore Technologies, Ltd.,

• Macrogen, Inc.,

• Eurofins Scientific,

• Myriad Genetics,

• Bio-Rad Laboratories, Inc.,

• Pieriandx,

• Roche Holding Ag,

• Genomatix Gmbh,

• DNASTAR Inc.,

• Macrogen Inc.

• Helicos BioSciences.

Request Free Sample Copy of the Report @ https://www.researchformarkets.com/sample/next-generation-sequencing-global-market-172050

Next-generation sequencing enables rapid sequencing and produces millions of DNA and RNA sequences. It is otherwise called as massively parallel sequencing technology used in personalized medicines, clinical applications, animal research and other applications.

Depending upon the End Users, the Genetic Screening is a method used to provide important information on gene function as well as the molecular events that underlie a biological process or pathway or identify and select for individuals who possess a phenotype of interest in a mutagenized population. It totally depends on the accuracy of the test, the reliability of the interpretation of the results and the ability to treat the condition based on the quality. Apart from these, it can lessen the anxiety of not knowing the possibility of developing a disease and give a tremendous sense of relief.

By geography, North America is expected to surpass the other regions throughout the forecast period due to the support from various government bodies, like NHGRI (National Human Genome Research Institute, US) and fund research on the genome's structure, function, and role in health and disease.

TYPE OF SEQUENCING COVERED:

• Whole Genome Sequencing

• Targeted Resequencing

• Whole Exome Sequencing

• RNA Sequencing

• CHIP Sequencing

• De Novo Sequencing

• Methyl Sequencing

• Pre-sequencing

PRODUCTS COVERED:

• Instruments

• Reagents & Consumables

• Services

• Platforms

APPLICATIONS COVERED:

• Reproductive Health

• Oncology

• HLA Typing/Immune System Monitoring

• Metagenomics, Epidemiology & Drug Development

• Agrigenomics & Forensics

• Consumer Genomics

• Clinical Investigation

END USERS COVERED:

• Hospitals

• Academics

• Biotech and Pharmaceutical Firms

• Next Generation Sequencing Market By Application

• Drug Discovery/Personalized Medicine

• Genetic Screening

• Diagnostics/Infectious Diseases

• Agriculture and Animal Research

• Other End Users

Request for Report Brochure for Latest Industry Insights @ https://www.researchformarkets.com/reports/next-generation-sequencing-global-market-172050

MAJOR CHAPTERS COVERED IN NEXT GENERATION SEQUENCING MARKET RESEARCH ARE:

1 Executive Summary

2 Preface

3 Market Trend Analysis

4 Porters Five Force Analysis

5 By Type of Sequencing

6 By Product

7 By Application

8 By End User

9 By Geography

10 Key Developments

11 Company Profiling

What Our Report Offers:

- Market share assessments for the regional and country level segments

- Market share analysis of the top industry players

- Strategic recommendations for the new entrants

- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets

- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)

- Strategic recommendations in key business segments based on the market estimations

- Competitive landscaping mapping the key common trends

- Company profiling with detailed strategies, financials, and recent developments

- Supply chain trends mapping the latest technological advancements

Customization Options

• All segmentation provided above in this report is represented at country level and can be customized according to needs.

• All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization).

Reasons to Purchase this Report

· Current and future of global oncology nutrition market outlook in the developed and emerging markets

· The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.

· Regions/countries that are expected to witness the fastest growth rates during the forecast period

· The latest developments, market shares, and strategies that are employed by the major market players

Inquiry Before Buying@ https://www.researchformarkets.com/inquiry/next-generation-sequencing-global-market-172050

About Research for Markets:

Research for Markets indulges in detailed and diligent research on different markets, trends and emerging opportunities in the successive direction to cater to your business needs. We have established the pillars of our flourishing institute on the grounds of Credibility and Reliability. RFM delve into the markets across Asia Pacific, North America, South America, Europe, Middle East and Africa.

Contact:

Mr. A Naidu

Research for Markets

Tel: +44 8000-4182-37 (UK)

Email: alan.naidu@researchformarkets.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Next Generation Sequencing Market to grow at a CAGR of 18.7% by 2026: Top Key Players Thermo Fisher Scientific, Roche, Illumina, QIAGEN, PerkinElmer, Inc., Agilent Technologies Pacific Biosciences , Myriad Genetics , Bio-Rad Laboratories and Eurofins here

News-ID: 1270184 • Views: 368

More Releases from Research for Markets

Oilfield Services Market Competitive Outlook with Baker Hughes, a GE company, Ha …
The market report titled Oilfield Services Market has company analysis, history, and future overview, global sales trends by 2025. It will be one of the most comprehensive and important additions for growth of the business through Oilfield Services Market research studies. The Oilfield Services Market research report comprises of a detailed analysis of the vendor landscape and thorough company profiling of leading players of the worldwide market. This business document
Annuloplasty Rings Market Competitive Outlook | Medtronic, Edwards Lifesciences, …
Global Annuloplasty Rings Market analysis report is a historical overview and comprehensive study on the current & future market of the ABC industry. This business research document puts forward an in-depth evaluation of each crucial aspect of the worldwide market that relates to the Annuloplasty Rings Market size, market share, market growth factor, key vendors, revenue, top regions, industry trends, product demand, sales volume, capacity, cost structure,
Ventilators Market Top Players are are benefiting from the coronavirus | BD, GE …
The Ventilators Market report has been generated by considering a common theme throughout the marketing industry that suggests strategy and research need stronger alignment. RFM team has firm expertise in making extensive reports that cover all the necessary details about Ventilators Market assessments such as major technological improvement in the industry. The information and flow of this Ventilators Market report can be employed by marketers from all walks of
ICU Ventilator Market Competitive Outlook | Getinge, Koninklijke Kentalis, Phili …
ICU Ventilator Market report enables clients to enhance business efficiency and focus on other core aspects of operations rather than wasting time in market research and reporting needs. ICU Ventilator Market instructions provided in this market analysis report are very specific and research-backed. For getting customization of the report, reach RFM team via email or phone. This ICU Ventilator Market analysis report delivers key data about the product portfolios, product

All 5 Releases


More Releases for Sequencing

Precision Medicine Market Report 2018: Segmentation by Technology (Genomics, Tra …
Global Precision Medicine market research report provides company profile for Abbott Laboratories, Almac Group, Ltd, Asuragen, Inc., Cepheid Inc, Cetics Healthcare Technologies GmbH, Ge Healthcare, Glaxosmithkline Plc, Intomics A/S., Biocrates Life Sciences Ag, Pfizer Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth
Next Wave in DNA Sequencing Market
Sequencing by synthesis (SBS), is one of the most influential and greatly adopted DNA sequencing technologies used by researchers and scientist globally. This technology offers a massive sequence throughput at modest costs in a single sequencing run. DNA Sequencing Market was valued at $5,156 million in 2016 and is expected to reach $18,284 million in 2023, registering a CAGR of 19.6% from 2017 to 2023. DNA sequencing is a technology in
Next Generation Sequencing Market Global Analysis and Forecasts by Service (Geno …
ReportsWeb.com has announced the addition of the “Next Generation Sequencing Market to 2025”, the report classifies the global Next Generation Sequencing Market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth. The next generation market is estimated to account for US$ 26,501.2 Mn by the end of 2025, escalating at a CAGR of 21.1% during the
Next Generation Sequencing Market By Key Manufacturers (Illumina, Qiagen, Perkin …
Next generation sequencing (NGS) is the technology which is used to align millions of small fragments of DNA simultaneously that are capable of processing multiple DNA sequences in parallel. The arrival of rapid DNA sequencing methods has significantly enhanced biological and medical research and discovery. The next generation sequencing market is anticipated to grow at a CAGR of 21.1% and reach US$ 26.5Bn by 2025. Increasing application of NGS in clinical
Pyro Sequencing Market: Business Intelligence & Market Insights
Pyro sequencing is a DNA sequencing technology based on the principle of sequencing-by-synthesis. The method consist of series of four enzymatic steps to detect sequence of nuclei acid during synthesis. Pyro sequencing can be easily automated and provides highly accurate results. The method is highly suitable for analysis of single nucleotide polymorphism and sequencing of small fragment of DNA. Pyro sequencing techniques consist of series of sequential steps for detection
Next-generation Sequencing Market
Next-generation sequencing or high throughput sequencing are advanced DNA sequencing technologies, including Illumina (Solexa) sequencing, Roche 454 sequencing, and Ion torrent: Proton/ PGM sequencing, SOLiD sequencing. Next-generation sequencing technologies have a number of advantages such as high speed, flexibility, high throughput, and reduced sequencing cost. Next-generation sequencing has ability to produce terabytes of nucleotide sequence data in a lone sequencing procedure. The NGS technology is developing at a rapid rate,